AURKB and breast cancer: showed that the analysis of a gene signature related to mitosis control, orchestrated by marker 14-3-3ζ, was able to control the resistance profile to endocrine therapy in BC, influencing the expression of markers involved with CLUSTER 1, such as FOXM1 and AURKB [76].